TLDR: Matthew Alaofin, a Senior Advisor at Dell Technologies, USA, highlighted at the IOCS 2025 event that significant investments in autonomous Artificial Intelligence (AI) and the Internet of Things (IoT) are crucial for shaping the future of healthcare and cybersecurity. He noted a shift towards advanced AI agents (Level 3 and Level 4) that can operate independently, driving efficiency and faster results. While substantial investments are already flowing into cybersecurity, Alaofin emphasized the need for increased focus and funding in the healthcare sector, particularly in ophthalmology, to fully realize the transformative potential of these technologies.
Matthew Alaofin, a Senior Advisor at Dell Technologies, USA, recently underscored the critical role of investments in autonomous Artificial Intelligence (AI) and the Internet of Things (IoT) in fundamentally transforming the healthcare and cybersecurity landscapes. Speaking at the IOCS 2025 conference, themed ‘Applications of IoT, Ophthalmologist and Cybersecurity in Digital tech,’ Alaofin detailed the current trajectory of technological advancement.
According to Alaofin, the industry is witnessing a substantial influx of capital into advanced AI, specifically ‘level three and level four artificial intelligence.’ He stated, “This is where the industry is headed. Level four is a more advanced AI agent where a lot of companies particular in the US are already putting investment. This is going to help in efficiency and achieving results faster. Companies are beginning to invest in these technologies and setting the groundwork.” This signifies a move towards AI systems capable of independent action, reducing the need for constant human intervention.
He further elaborated on the symbiotic relationship between AI and IoT, explaining, “IoT systems have sensors which now pass data to the AI component that analyses the data and then comes up with whatever result. The synergy between both is beautiful and has a lot of benefit for industries specifically for Ophthalmology and cybersecurity. We have seen that in cybersecurity but need to see more in Ophthalmology because the potentials are there and investments are huge.” While many of these innovations are still in pilot stages, billions of dollars are already being committed to securing and developing these technologies.
Alaofin highlighted that AI is evolving from passive applications requiring human input to ‘autonomous agents which can act independently.’ He cited promising growth forecasts, with IoT Edge spending in Healthcare projected to grow at a Compound Annual Growth Rate (CAGR) of +10 percent, and AI Services at a CAGR of +15 percent. Despite these figures, he acknowledged that a majority of these investments are currently concentrated in the cybersecurity sector. He issued a call for greater investment in healthcare systems, asserting that “Agentic AI will deliver transformative value to healthcare systems by introducing autonomous, adaptive, and goal-oriented intelligence across both clinical and operational domains.”
Also Read:
- Advancing AI in Eye Care: A Bibliometric Review of Ethical Considerations and Emerging Trends in Ophthalmology
- Workforce Evolution: How Automation and AI are Redefining Roles Across Tech, Finance, and Healthcare by 2025
This collaboration, he added, will lead to ‘optimized operations, improved resource efficiency, and enhanced user experiences across various industries or domains.’
